Intra and Inter Reliability and Validity of the Turkish Version of Ottowa Sitting Scale in Intensive Care Unit Survivors
2 de mayo de 2019 actualizado por: Busra Aktas, Izmir Katip Celebi University
Introduction-Objective: Balance evaluation is one of the most important components of physical examination. Studies on equilibrium assessment in different research groups; It includes measurements that assess the seating balance, which does not require complex measurements or ambulation.
In the literature, there is no clear information about balance effect in intensive care patients who can not be ambulated due to loss of advanced muscle strength, especially in the early period.
Ottowa Sitting Scale is a scale in which the balance is evaluated in the sitting position and it has no validity and reliability in Turkish.
Therefore, the aim of this study is to examine the reliability and validity of the Ottowa Sitting Scale Turkish version between measurements and measurements.
Descripción general del estudio
Estado
Desconocido
Descripción detallada
In recent years, the mortality rate has decreased in an intensive care unit with the medical and technological developments related to intensive care treatments and the rate of discharge from intensive care unit (ICU) has increased.
However, as the length of hospitalization in the intensive care unit prolonged, the functionalities of the patients were restricted due to changes in the musculoskeletal and cardiovascular system.
Inactivity, inflammation, the use of pharmacological agents and the presence of neuromuscular syndromes associated with the critical disease lead to decreased muscle dysfunction and exercise tolerance in patients in the intensive care unit.
These changes cause the health-related quality of life to be worse in people with critical illness a few months after discharge.
Balance; muscle strength is affected by changes in sensory information, postural control and vestibular arrangements from the lower extremity.
Studies on equilibrium assessment in different research groups; It includes measurements that assess the seating balance, which does not require complex measurements or ambulation.
In the literature, there is no clear information about balance effect in intensive care patients who can not be ambulated due to loss of advanced muscle strength, especially in the early period.
The Ottowa Sitting Scale is a scale in which the balance is evaluated in the sitting position and there is no validity and reliability in Turkish.
For this reason, the aim of this study is to examine the reliability and validity between measurements and measurements of the Ottowa Sitting Scale's Turkish version.
More than one physiotherapist scores patients for validity between the measurements.
For the validity of the measurements, a physiotherapist scores the patient twice in two weeks intervals.
Tipo de estudio
De observación
Inscripción (Actual)
80
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Cigli
-
İzmir, Cigli, Pavo
- Izmir University of Health Sciences Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años y mayores (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Método de muestreo
Muestra de probabilidad
Población de estudio
80
Descripción
Inclusion Criteria:
- Volunteer to participate in the study
- To understand Turkish commands
- To be able to be independent in the previous functional status
- Sleep at least 24 hours in intensive care
Exclusion Criteria:
- Do not want to participate in the study
- Central or peripheral neurological damage
- Don't understand Turkish commands
- Unconsciousness
- Arrhythmia
- Acute myocardial infarction
- Hemodynamic instability (Blood pressure> 200 or <80; Heart rate <40 or> 130, O2 saturation <88%)
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: Otro
- Perspectivas temporales: Transversal
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Ottowa Sitting Scale
Periodo de tiempo: 1 day
|
It is a scale that does not require ambulation, is able to maintain static sitting position in the sitting position, can move in short distance, can move long distance, body rotation ability and ability to move on the hip can be fulfilled.
The scoring of each unit varies between 0-4 and the maximum score is 40.
|
1 day
|
|
Functional Independence Scale (FIM)
Periodo de tiempo: 1 day
|
FIM shows the degree of independence in the basic physical and cognitive activities of the individual in daily life.
FIM consists of 18 questions and mainly measures 2 parameters (1- physical / motor function, 2- cognitive / cognitive function).
Each item is scored at 7 levels (1-7), 'level 1 yardım means full help, and Her level 7 lan means full independence.
FIM total score is between 18-126 points.
The higher the individual's score, the higher the level of independence.
|
1 day
|
|
Berg Balance Test
Periodo de tiempo: 1 day
|
It consists of 14 questions in which it is evaluated whether or not the balance related tasks can be fulfilled in the changing spectrum from sitting position to standing up to one foot.
0: cannot do 4: is scored as doing independently.
The total score is 56.
The risk of a fall from 0 to 20 is high, the risk of a fall from 21 to 40 is considered to be low and the risk of a fall from 41 to 56 is considered low.
|
1 day
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Director de estudio: Ilknur Gursan, Izmir Katip Celebi University
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
13 de febrero de 2019
Finalización primaria (Anticipado)
1 de agosto de 2019
Finalización del estudio (Anticipado)
30 de septiembre de 2019
Fechas de registro del estudio
Enviado por primera vez
30 de abril de 2019
Primero enviado que cumplió con los criterios de control de calidad
2 de mayo de 2019
Publicado por primera vez (Actual)
3 de mayo de 2019
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
3 de mayo de 2019
Última actualización enviada que cumplió con los criterios de control de calidad
2 de mayo de 2019
Última verificación
1 de mayo de 2019
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- IzmırIKCU
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .